NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework ()
Duration
not specified
Value
£26M
Sector
MISCELLANEOUS
Published
30 Jan 2026
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 9 suppliers

1 buyer

9 suppliers

Description

Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026 Offer reference number: CM/TNS/25/5735 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months) Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months) Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Award Detail

1 Zentiva Pharma (London)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
2 Thornton & Ross (Huddersfield)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
3 Teva (Castleford)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
4 Glenmark Pharmaceuticals Europe (Harrow)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
5 Farmak Pharmaceuticals (Hull)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
6 DR Reddys Laboratories (Cambridge)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
7 Celix Pharma (London)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
8 Amarox (Harrow)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.
9 Accord (Devon)
  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin
  • Reference: 2
  • Value: £25,881,000 [share]
  • Awarded to group of suppliers.

CPV Codes

  • None found

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-05936a
  • FTS 008310-2026

Domains